Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO

AC5 KO 中提高运动耐力的骨骼肌基础

基本信息

  • 批准号:
    8725726
  • 负责人:
  • 金额:
    $ 44.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Improving exercise tolerance, one of the major goals of physicians treating patients with cardiovascular disease, can be achieved either by improving cardiac output and blood flow to skeletal muscle, or by improving energy metabolism in skeletal muscle, or both. However, less is known regarding specific molecular pathways that might be approached therapeutically to improve exercise tolerance. In the past, we have demonstrated that the adenylyl cyclase type 5 (AC5) knockout (KO) mouse lives one third longer than wild type and is protected against aging induced cardiomyopathy, and the development of heart failure induced by either chronic catecholamine or pressure overload stress. The current project is based on these studies and our preliminary data demonstrating that AC5 KO mice exhibit increased exercise capacity. Our overall hypothesis is that AC5 is a critical enzyme affecting stress resistance and exercise capacity. The goal of this project is to examine mechanisms involved in AC5 inhibition, which could lead to a novel approach to improve exercise performance. There are two major hypotheses: HYPOTHESIS A: AC5 inhibition permits enhanced exercise performance due to improved limb blood flow through enhanced vasodilator mechanisms or angiogenesis, whereas improved cardiac function and cardiac output are less likely mechanisms. HYPOTHESIS B: AC5 inhibition permits enhanced exercise performance due to improved mitochondrial function and/or resistance to oxidative stress and/or improved glucose utilization. The implications for Public Health are clear: improving exercise tolerance will have broad significance for aging, heart disease, most other diseases and even for the young, healthy population.
描述(由申请人提供):提高运动耐量是医生治疗心血管疾病患者的主要目标之一,可以通过改善心输出量和骨骼肌血流量或改善骨骼肌的能量代谢或两者来实现。然而,关于可能在治疗上接近以改善运动耐量的特定分子途径知之甚少。在过去,我们已经证明,腺苷酸环化酶5型(AC 5)敲除(KO)小鼠的寿命比野生型长三分之一,并防止衰老诱导的心肌病,以及慢性儿茶酚胺或压力超负荷应激诱导的心力衰竭的发展。当前项目基于这些研究和我们的初步数据,证明AC 5 KO小鼠表现出运动能力增强。我们的总体假设是,AC 5是影响应激抵抗力和运动能力的关键酶。该项目的目标是研究AC 5抑制的机制,这可能会导致一种新的方法来改善运动表现。有两个主要假设:假设A:AC 5抑制允许增强运动表现,这是由于通过增强血管扩张机制或血管生成改善肢体血流,而改善心脏功能和心输出量是不太可能的机制。假设B:由于改善的线粒体功能和/或对氧化应激的抗性和/或改善的葡萄糖利用,AC 5抑制允许增强的运动表现。对公共卫生的影响是明确的:提高运动耐量将对衰老,心脏病,大多数其他疾病,甚至年轻,健康的人群具有广泛的意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHEN F VATNER其他文献

STEPHEN F VATNER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHEN F VATNER', 18)}}的其他基金

A Novel Pharmacological Inhibitor of Adenylyl Cyclase Type 5 to Treat Alzheimer's Disease
一种治疗阿尔茨海默病的新型 5 型腺苷酸环化酶药理抑制剂
  • 批准号:
    10608477
  • 财政年份:
    2022
  • 资助金额:
    $ 44.88万
  • 项目类别:
Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO
RGS14 KO 中骨骼肌和棕色脂肪机制介导心血管危险因素保护
  • 批准号:
    9900047
  • 财政年份:
    2017
  • 资助金额:
    $ 44.88万
  • 项目类别:
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk
sFRP3 肌细胞/血管交互作用诱导的血管生成保护
  • 批准号:
    9900045
  • 财政年份:
    2017
  • 资助金额:
    $ 44.88万
  • 项目类别:
Vascular Protection in Hibernating Woodchucks
冬眠土拨鼠的血管保护
  • 批准号:
    9020511
  • 财政年份:
    2016
  • 资助金额:
    $ 44.88万
  • 项目类别:
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
RGS 14 破坏、血管效应导致心脏保护
  • 批准号:
    8888575
  • 财政年份:
    2015
  • 资助金额:
    $ 44.88万
  • 项目类别:
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
RGS 14 破坏、血管效应导致心脏保护
  • 批准号:
    9102537
  • 财政年份:
    2015
  • 资助金额:
    $ 44.88万
  • 项目类别:
Intrinsic Vascular Smooth Muscle Cell Stiffness
内在血管平滑肌细胞硬度
  • 批准号:
    8764029
  • 财政年份:
    2013
  • 资助金额:
    $ 44.88万
  • 项目类别:
Longevity and Stress Resistance
长寿和抗压能力
  • 批准号:
    8682004
  • 财政年份:
    2013
  • 资助金额:
    $ 44.88万
  • 项目类别:
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KO
RGS14 KO 中提高运动耐力的骨骼肌基础
  • 批准号:
    9513046
  • 财政年份:
    2011
  • 资助金额:
    $ 44.88万
  • 项目类别:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
AC5 KO 中提高运动耐力的骨骼肌基础
  • 批准号:
    8193326
  • 财政年份:
    2011
  • 资助金额:
    $ 44.88万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 44.88万
  • 项目类别:
Parkinson's disease and aging affect neural activation during continuous gait alterations to the split-belt treadmill: An [18F] FDG PET Study.
帕金森病和衰老会影响分体带跑步机连续步态改变期间的神经激活:[18F] FDG PET 研究。
  • 批准号:
    400097
  • 财政年份:
    2019
  • 资助金额:
    $ 44.88万
  • 项目类别:
The elucidation of the mechanism by which intestinal epithelial cells affect impaired glucose tolerance during aging
阐明衰老过程中肠上皮细胞影响糖耐量受损的机制
  • 批准号:
    19K09017
  • 财政年份:
    2019
  • 资助金额:
    $ 44.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Does aging of osteocytes adversely affect bone metabolism?
骨细胞老化会对骨代谢产生不利影响吗?
  • 批准号:
    18K09531
  • 财政年份:
    2018
  • 资助金额:
    $ 44.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Links between affect, executive function, and prefrontal structure in aging: A longitudinal analysis
衰老过程中情感、执行功能和前额叶结构之间的联系:纵向分析
  • 批准号:
    9766994
  • 财政年份:
    2018
  • 资助金额:
    $ 44.88万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 44.88万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 44.88万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 44.88万
  • 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
  • 批准号:
    9925164
  • 财政年份:
    2016
  • 资助金额:
    $ 44.88万
  • 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
  • 批准号:
    9345997
  • 财政年份:
    2016
  • 资助金额:
    $ 44.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了